bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.12.15.520669

Reducing High Pressure Processing Costs: Efficacious Alternatives to Current Standard Procedures in the Food Manufacturing Industry

Abstract

As a result of recent advancements in design and optimization of high-pressure processing units, the technology is gaining rapid adoption across various sectors of food manufacturing, thus requiring extensive microbiological hurdle validation studies for efficacious and feasible utilization of the technology. Commercial adoption of high-pressure processing is gaining momentum of industrial importance because of recent advances in the engineering of pressure-based pasteurization units. With tremendous ability of plethora of microorganisms to move towards fitness through vertical and horizontal gene transfer mechanisms, prevention of natural and anthropogenic pathogens of public health concern is a daunting task and a moving target. Current study discusses, Reducing the Cost Associated with High Pressure Processing: Efficacious Alternatives to the Current Standard Procedure in the Food Manufacturing Industry, with microbiological challenge studies for inactivation of the pathogen exposed to various times and intensity levels of elevated hydrostatic pressure (Pressure BioScience Inc.). Elevated hydrostatic pressure is a non-thermal procedure that exposes pathogens to pressures of up to 80,000 PSI (>550 MPa). Various times (3, 4, and 5 minutes) at pressure intensity levels of 600 MPa, (87K PSI), 550 MPa (79K PSI), 480 MPa (70K PSI), 415 MPa (60K PSI), and 345 MPa (50K PSI) of elevated hydrostatic pressure (Hub880 Explorer, Pressure BioScience Inc), were investigated at 4{degrees}C and for 45{degrees}C for inactivation of Shiga toxin-producing Escherichia coli O157:H7 (STEC) (ATCC numbers BAA 460, 43888, 43894, 35150, 43889, and 43890) respectively, Big Six non-O157 Shiga toxin-producing E. coli (nSTEC) (ATCC numbers BAA 2196, 2193, 2215, 2440, 2219, and 2192) respectively, Salmonella serovars (ATCC numbers 13076, 8387, 6962, 9270, and 14028) respectively, and Listeria monocytogenes (ATCC numbers 51772, 51779, BAA 2657, and BAA 13932). Studies were conducted in two biologically independent repetitions as a blocking factors of a randomized complete block design containing three repetitions per time/treatment within each block, analyzed statistically using GLM procedures of SAS 9.4 software at type one error level at 5% using Tukey- and Dunnett-adjusted ANOVA. A Barocycler Hub840 unit (Pressure BioScience Inc., Southeastern, MA), equipped with a water jacket and circulating water bath for precise application of hydrostatic pressure and controlled temperature was utilized. Up to 0.95 and 2.60 log reductions (P<0.05) of non-habituated Shiga toxin-producing Escherichia coli Non-O157 at planktonic stages were achieved using application of pressure at 345 MPa and 550 MPa for 5 minutes and 4 minutes, respectively at 4{degrees}C. Up to 4.42 and 5.10 log reductions (P<0.05) of non-habituated Shiga toxin-producing Escherichia coli Non-O157 at planktonic stages were achieved using application of pressure at 345 MPa and 480 MPa for 5 minutes and 4 minutes, respectively at 45{degrees}C. Up to 1.63 and 3.14 log reductions (P < 0.05) of non-habituated Listeria monocytogenes at planktonic stages were achieved using application of pressure at 345 MPa and 600 MPa for 5 minutes and 3 minutes, respectively at 4{degrees}C. Up to 4.91 and 6.37 log reductions (P < 0.05) of non-habituated Listeria monocytogenes at planktonic stages were achieved using application of pressure at 550 MPa and 480 MPa for 4 minutes, respectively at 45{degrees}C. Up to 2.87 and 5.82 log reductions (P< 0.05) of non-habituated Salmonella serovars at planktonic stages were achieved using application of pressure at 345 MPa and 550 MPa for 5 minutes and 4 minutes, respectively at 4{degrees}C. Up to 5.17 and 6.79 log reductions (P< 0.05) of non-habituated Salmonella serovars at planktonic stages were achieved using application of pressure at 415 MPa and 600 MPa for 5 minutes and 3 minutes, respectively at 45{degrees}C. Up to 0.86 and 1.35 log reductions (P<0.05) of non-habituated Shiga toxin-producing Escherichia coli O157:H7 at planktonic stages were achieved using application of pressure at 345 MPa and 480 MPa for 5 minutes and 4 minutes, respectively at 4{degrees}C. Up to 2.02 and 6.12 log reductions (P<0.05) of non-habituated Shiga toxin-producing Escherichia coli O157:H7 at planktonic stages were achieved using application of pressure at 345 MPa and 550 MPa for 5 minutes and 4 minutes, respectively at 45{degrees}C. Results of this study could be incorporated as a part of predictive public health microbiology modeling and risk assessment analysis for prevention of pathogen related disease and illness episodes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Akwu, A. V. S., Allison, A. E., Adhikari, J., Henry, M., Inman, W.. 2022-12-16. Reducing High Pressure Processing Costs: Efficacious Alternatives to Current Standard Procedures in the Food Manufacturing Industry. https://doi.org/10.1101/2022.12.15.520669

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗